Beth Israel Deaconess Medical Center

Boston, Massachusetts
Chief of Pathology, Beth Israel Deaconess Medical Center
Mallinckrodt Distinguished Professor of Pathology, Harvard Medical School

Research

Harold F. Dvorak, M.D., discovered that tumor cells secrete a vascular endothelial growth factor (VEGF) and this seminal discovery provided the molecular basis for the field of angiogenesis (meaning “blood vessel formation”). Angiogenesis makes it possible for tumors to grow and spread, and Dr. Dvorak’s discovery helped pave the way for research on anti-angiogenesis treatments that can halt and even reverse tumor growth.

In 2004, the first VEGF-targeting anti-angiogenic drug Avastin® was approved by the FDA for the treatment of colorectal cancer, and, today, in addition to colorectal cancer, Avastin is approved for the treatment of non-small cell lung cancer, renal cell carcinoma, the aggressive brain cancer glioblastoma multiforme (GBM) and certain types of cervical and ovarian cancers. More than 280 clinical trials are currently investigating the use of Avastin in over 50 tumor types.

Dr. Dvorak’s recent research projects have led to the identification and characterization of at least six different kinds of blood vessels in tumors. While current anti-angiogenic therapies primarily act against only one of them, his research group has already discovered new therapeutic targets on the other five vessel types. They are aiming to improve the effectiveness of anti-angiogenic therapy by attacking the entire tumor environment, providing opportunities for new types of anti-cancer treatments.

Bio

Harold F. Dvorak, M.D. attended Princeton University and Harvard Medical School. He started his career with residency training in pathology at Massachusetts General Hospital (MGH) and spent two years as a post-doctorate at the National Institutes of Health. Dr. Dvorak worked as a staff pathologist at MGH for 16 years and then spent almost 30 years at Beth Israel Deaconess Medical Center.

Dr. Dvorak served on the faculty of Harvard Medical School starting in 1967 and, throughout his career, was a visiting professor at numerous national and international scientific conferences. In addition to his long-running fellowship with NFCR, he was a fellow of the American Association for the Advancement of Science and served as President of the American Society for Investigative Pathology.

Dr. Dvorak was the first winner of NFCR’s Szent-Györgyi Prize for Progress in Cancer Research in 2006 for his discovery of VEGF. He also won the 2002 Rous-Whipple award from the American Society for Investigative Pathology and the 2005 Grand Prix Lefoulon-Delalande from the Institut de France.

Related Content

Rectal Cancers Vanished After Immunotherapy Treatment

NFCR In the News: Addressing Deadly Brain Cancer, GBM

Vitamin-D Rich Foods & Colorectal Cancer Prevention

Colorectal cancer is the third most common cancer diagnosed in men and women in the United States. However, recent studies suggest there may be an effective way to reduce one’s risk. A team of researchers recently shared their exciting findings showing that eating greater amounts of vitamin D may help against developing colorectal cancer, particularly for those under age 50. The team analyzed data from nearly 95,000 women participating in a long-term study about diet and lifestyle. They found that those with high amounts of vitamin D in their diets—particularly from dairy products—had a 50% lower risk of developing young-onset colorectal cancer than those with lower amounts of the vitamin. Over the past decade, medical professionals have recorded a steady decline in colorectal cancer diagnoses. The decline has been attributed to the availability of effective screening and better adoption of lifestyle changes like healthy eating and exercise. However, that decline does not apply to younger people. In fact, colorectal cancer rates have been rising at an increased rate amongst people under 40.  A Growing Concern Academics and government experts have joined forces to solve the mystery of the rapid increase. However, the puzzle remains unsolved mainly. One of the most likely determinants is diet amongst this age group. The group of experts identified that in addition to not eating enough fruits and vegetables, this age group was deficient in vitamin D.  Further exploring this matter, researchers looked at data broken down between vitamin D absorbed via dietary sources and vitamin D absorbed from a supplement. Shockingly, the results were more favorable among participants who absorbed vitamin D from dietary sources. So, how can vitamin D be added to a diet? Vitamin D is fat-soluble, which means that it doesn’t dissolve in water and absorbs better when paired with some kind of fat. Meaning it’s more effective to choose dairy products that aren’t nonfat as the fat in the dairy helps to facilitate the body’s absorption of vitamin D. However, sources other than dairy help the body meet its vitamin D quota.  Salmon Salmon is a popular fatty fish and an excellent source of vitamin D. On average, wild-caught salmon packs 124% of the daily recommended value (DV) per 100 grams. It is important to note that farmed fish often have less vitamin D; however, it still surpasses 25% of the DV on average. Check out a tasty salmon recipe here. Egg Yolks Eggs can hold a significant amount of vitamin D. Still, it can vary greatly depending on sun exposure and the vitamin D content of the chicken feed. When given the same meal, pasture-raised chickens that roam outside in the sunlight produce eggs with levels 3–4 times higher. On average, a typical egg yolk contains 5% of the DV. However, eggs from chickens given vitamin-D-enriched feed may have up to 7 times the DV! Try a tasty recipe to sneak some eggs onto the dinner plate here. Mushrooms Mushrooms are magical fungi that positively impact health in a variety of ways. Excluding fortified foods, mushrooms are the only good non-animal source of vitamin D. Like humans, mushrooms can synthesize […]